Cargando…

In Silico Screening and In Vitro Assessment of Natural Products with Anti-Virulence Activity against Helicobacter pylori

Helicobacter pylori is one of the most frequent human pathogens and a leading etiological agent of various gastric diseases. As stringent response, coordinated by a SpoT protein, seems to be crucial for the survivability of H. pylori, the main goal of this article was to use in silico computational...

Descripción completa

Detalles Bibliográficos
Autores principales: Spiegel, Maciej, Krzyżek, Paweł, Dworniczek, Ewa, Adamski, Ryszard, Sroka, Zbigniew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8746548/
https://www.ncbi.nlm.nih.gov/pubmed/35011255
http://dx.doi.org/10.3390/molecules27010020
_version_ 1784630613485027328
author Spiegel, Maciej
Krzyżek, Paweł
Dworniczek, Ewa
Adamski, Ryszard
Sroka, Zbigniew
author_facet Spiegel, Maciej
Krzyżek, Paweł
Dworniczek, Ewa
Adamski, Ryszard
Sroka, Zbigniew
author_sort Spiegel, Maciej
collection PubMed
description Helicobacter pylori is one of the most frequent human pathogens and a leading etiological agent of various gastric diseases. As stringent response, coordinated by a SpoT protein, seems to be crucial for the survivability of H. pylori, the main goal of this article was to use in silico computational studies to find phytochemical compounds capable of binding to the active site of SpoT from H. pylori and confirm the ability of the most active candidates to interfere with the virulence of this bacterium through in vitro experiments. From 791 natural substances submitted for the virtual screening procedure, 10 were chosen and followed for further in vitro examinations. Among these, dioscin showed the most interesting parameters (the lowest MIC, the highest anti-biofilm activity in static conditions, and a relatively low stimulation of morphological transition into coccoids). Therefore, in the last part, we extended the research with a number of further experiments and observed the ability of dioscin to significantly reduce the formation of H. pylori biofilm under Bioflux-generated flow conditions and its capacity for additive enhancement of the antibacterial activity of all three commonly used antibiotics (clarithromycin, metronidazole, and levofloxacin). Based on these results, we suggest that dioscin may be an interesting candidate for new therapies targeting H. pylori survivability and virulence.
format Online
Article
Text
id pubmed-8746548
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-87465482022-01-11 In Silico Screening and In Vitro Assessment of Natural Products with Anti-Virulence Activity against Helicobacter pylori Spiegel, Maciej Krzyżek, Paweł Dworniczek, Ewa Adamski, Ryszard Sroka, Zbigniew Molecules Article Helicobacter pylori is one of the most frequent human pathogens and a leading etiological agent of various gastric diseases. As stringent response, coordinated by a SpoT protein, seems to be crucial for the survivability of H. pylori, the main goal of this article was to use in silico computational studies to find phytochemical compounds capable of binding to the active site of SpoT from H. pylori and confirm the ability of the most active candidates to interfere with the virulence of this bacterium through in vitro experiments. From 791 natural substances submitted for the virtual screening procedure, 10 were chosen and followed for further in vitro examinations. Among these, dioscin showed the most interesting parameters (the lowest MIC, the highest anti-biofilm activity in static conditions, and a relatively low stimulation of morphological transition into coccoids). Therefore, in the last part, we extended the research with a number of further experiments and observed the ability of dioscin to significantly reduce the formation of H. pylori biofilm under Bioflux-generated flow conditions and its capacity for additive enhancement of the antibacterial activity of all three commonly used antibiotics (clarithromycin, metronidazole, and levofloxacin). Based on these results, we suggest that dioscin may be an interesting candidate for new therapies targeting H. pylori survivability and virulence. MDPI 2021-12-21 /pmc/articles/PMC8746548/ /pubmed/35011255 http://dx.doi.org/10.3390/molecules27010020 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Spiegel, Maciej
Krzyżek, Paweł
Dworniczek, Ewa
Adamski, Ryszard
Sroka, Zbigniew
In Silico Screening and In Vitro Assessment of Natural Products with Anti-Virulence Activity against Helicobacter pylori
title In Silico Screening and In Vitro Assessment of Natural Products with Anti-Virulence Activity against Helicobacter pylori
title_full In Silico Screening and In Vitro Assessment of Natural Products with Anti-Virulence Activity against Helicobacter pylori
title_fullStr In Silico Screening and In Vitro Assessment of Natural Products with Anti-Virulence Activity against Helicobacter pylori
title_full_unstemmed In Silico Screening and In Vitro Assessment of Natural Products with Anti-Virulence Activity against Helicobacter pylori
title_short In Silico Screening and In Vitro Assessment of Natural Products with Anti-Virulence Activity against Helicobacter pylori
title_sort in silico screening and in vitro assessment of natural products with anti-virulence activity against helicobacter pylori
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8746548/
https://www.ncbi.nlm.nih.gov/pubmed/35011255
http://dx.doi.org/10.3390/molecules27010020
work_keys_str_mv AT spiegelmaciej insilicoscreeningandinvitroassessmentofnaturalproductswithantivirulenceactivityagainsthelicobacterpylori
AT krzyzekpaweł insilicoscreeningandinvitroassessmentofnaturalproductswithantivirulenceactivityagainsthelicobacterpylori
AT dworniczekewa insilicoscreeningandinvitroassessmentofnaturalproductswithantivirulenceactivityagainsthelicobacterpylori
AT adamskiryszard insilicoscreeningandinvitroassessmentofnaturalproductswithantivirulenceactivityagainsthelicobacterpylori
AT srokazbigniew insilicoscreeningandinvitroassessmentofnaturalproductswithantivirulenceactivityagainsthelicobacterpylori